Borosil Scientific Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹104 Cr +4.7% YoYSee revenue, profit and what management said. You are viewing Q1 FY27.
BS

Borosil Scientific Ltd

Q1 FY27Industrial Products

Borosil Scientific Q1 FY27: Revenue ₹106.8 Cr, PAT ₹4.4 Cr

Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹100Cr
+12.2% YoY
−24.3% QoQ
Net profit
₹7Cr
+1387% YoY
−68.2% QoQ
Margin
11.07%
+1.1 pp YoY
−12.5 pp QoQ

Based on Borosil Scientific Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹116
Market cap₹1.1K Cr
P/E23.9

The short version

Q1FY27 Consolidated net sales: ₹106.8 Cr, up 11.2% YoY (Q1FY26: ₹96.0 Cr) - Standalone net sales: ₹99.9 Cr, up 12.2% YoY (Q1FY26: ₹89.0 Cr) - EBITDA (Consolidated): ₹8.7 Cr, up 50.1% YoY (Q1FY26: Q1FY27 Consolidated EBITDA: ₹8.7 crores, up 50.1% YoY - Q1FY27 Consolidated EBITDA Margin: 8.2% - Q1FY27 Consolidated PAT: ₹4.4 crores, up 203.5% YoY - Q1FY27 Standalone EBITDA: ₹11.5 crores, up 15.3% YoY - Q1FY27 Standalone EBITDA Margin: 11.5% - Q1FY27 Standalone PAT: ₹6.8 crores, up 1396% YoY - Explicit Margin Outlook: Medium-term goal to improve EBITDA margins through emphasis on high-margin Process Sciences and lab equipment, maintaining an annual pricing strategy, vigilant expense control, and focus on renewable energy (Page 18-19).

From Borosil Scientific Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Q1FY27 Consolidated net sales: ₹106.8 Cr, up 11.2% YoY (Q1FY26: ₹96.0 Cr)
  • Standalone net sales: ₹99.9 Cr, up 12.2% YoY (Q1FY26: ₹89.0 Cr)
  • EBITDA (Consolidated): ₹8.7 Cr, up 50.1% YoY (Q1FY26: ₹5.8 Cr)
  • EBITDA (Standalone): ₹11.5 Cr, up 15.3% YoY (Q1FY26: ₹9.9 Cr)
  • Category-wise Q1FY27 sales growth YoY:
  • Lab Consumables: ₹45.8 Cr, flat (-0.1%)
  • Lab Equipment: ₹12.3 Cr, +31.4%
  • Process System: ₹8.5 Cr, +8.6%
  • Pharma Packaging: ₹23.1 Cr, +31.6%
  • Domestic Glassware: ₹15.3 Cr, +4.0%
  • Others: ₹1.7 Cr, +175.6%

2 more points from Borosil Scientific Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Borosil Scientific Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

It mentions: - Capital expenditure to expand volumes is underway, positioning Borosil Scientific Limited to participate in the next growth phase (Page 13). - The company leverages “Make in India” infrastructure featuring scalable capacity and energy-efficient plants (Page 13).

2 more points from Borosil Scientific Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Industrial Products

Ranked on what management guided this quarter

Guidance-ranked
1Hi-Tech Pipes
Rev 1Mar 1
Rev 1Mar 1
3
Rev 1Mar 2
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Borosil Scientific Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Borosil Scientific Ltd said on order book & pipeline — free account, 30 seconds.

Borosil Scientific Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Borosil Scientific Ltd Q1 FY27 results — key figures

Borosil Scientific Ltd Q1 FY27 reported results vs Q1 FY26, ₹ crore
₹ CrQ1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue10089+12.2%132-24.3%
Operating profit (EBITDA)119+24.8%31-64.4%
Operating margin11.07%9.95%+1.1 pp23.57%-12.5 pp
Profit before tax91+1310.6%29-67.7%
Net profit (PAT)70+1387%22-68.2%
EPS (₹)0.770.05+1440%2.42-68.2%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹104 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Industrial Products this season

  • Expo Engineering (Q1 FY27)

    Q1 FY27 Revenue from Operations: ₹13.75 crore, down from ₹17.85 crore in Q1 FY26 (approx. Key investor presentation takeaways from Expo Engineering and Projects

  • Shri Bajrang Alliance (Q1 FY27)

    Shareholding pattern as of 30 June 2026: Promoter 63.97%, Public 36.03%. Key investor presentation takeaways from Shri Bajrang Alliance Ltd's Q1 FY27 investor p

  • Bedmutha Industries (Q1 FY27)

    Revenue from Operations for the year ended March 31, 2026: Rs 1466.74 crores versus Rs 1049.33 crores for March 31, 2025, indicating a significant year-on-year…

  • Horizon Reclaim (Q1 FY27)

    Reported Revenue (₹ Cr): . Key investor presentation takeaways from Horizon Reclaim (India) Ltd's Q1 FY27 investor presentation — and how it ranks against secto

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Borosil Scientific Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Borosil Scientific Ltd Q1 FY27 results?

Q1FY27 Consolidated net sales: ₹106.8 Cr, up 11.2% YoY (Q1FY26: ₹96.0 Cr) - Standalone net sales: ₹99.9 Cr, up 12.2% YoY (Q1FY26: ₹89.0 Cr) - EBITDA (Consolidated): ₹8.7 Cr, up 50.1% YoY (Q1FY26: Q1FY27 Consolidated EBITDA: ₹8.7 crores, up 50.1% YoY - Q1FY27 Consolidated EBITDA Margin: 8.2% - Q1FY27 Consolidated PAT: ₹4.4 crores, up 203.5% YoY - Q1FY27 Standalone EBITDA: ₹11.5 crores, up 15.3% YoY - Q1FY27 Standalone EBITDA Margin: 11.5% - Q1FY27 Standalone PAT: ₹6.8 crores, up 1396% YoY - Explicit Margin Outlook: Medium-term goal to improve EBITDA margins through emphasis on high-margin Process Sciences and lab equipment, maintaining an annual pricing strategy, vigilant expense control, and focus on renewable energy (Page 18-19).

What is Borosil Scientific Ltd share price analysis?

Borosil Scientific Ltd currently shows a neutral. The stock trades at a P/E of 23.9 with a market cap of ₹1,064 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Borosil Scientific Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.